Trial Profile
Study on effects of cytokine targeted therapy on periodontal condition in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Adalimumab; Etanercept; Infliximab
- Indications Periodontitis; Rheumatoid arthritis
- Focus Therapeutic Use
- 18 Apr 2015 Status changed from recruiting to completed as per University Hospital Medical Information Network - Japan.
- 19 Jun 2014 New trial record